08-25-2019  6:57 am   •   PDX Weather    •   SEA weather  
  • 1
  • 2
  • 3
  • 4

NORTHWEST NEWS

Records: Portland Spent $1,100 per Night for Aide's Hotel

Documents show that Portland Mayor Ted Wheeler's office billed city taxpayers jumi,123 a night for an aide's hotel accommodations while at a conference

Money Crunch After Planned Parenthood Quits Federal Program

Clinics begin charging new fees, tapping financial reserves and intensifying fundraising

New Hate Crime Law Kicks In

SB577 requires state to better track bias crimes

Mayor: Show Extra Love at Portland Businesses After Protests

The City of Portland and more are offering deals and free parking downtown this weekend in an effort to generate some of the revenue lost during last weekend's political protests

NEWS BRIEFS

Local Actors Star in Haunting, Stripped-Down Macbeth

This fall, Chantal DeGroat, Dana Green, and Lauren Bloom Hanover star in a stripped-down production of Macbeth, directed by Adriana...

Albina Ministerial Alliance to Host Community Forum on Police Association Contract Aug. 26

Forum will take place at Maranatha Church beginning at 6 p.m. ...

Travel Portland Opens New Director Park Visitor Center

Hosts “Celebrating All Things Portland” grand opening weekend celebration ...

Police are Trying to Connect Floyd Leslie Hill to His Loved Ones

The Portland Police Bureau is asking for the community's help in locating the loved ones of Floyd Leslie Hill who passed away on...

New maps chart possible course for estuary restoration

ASTORIA, Oregon (AP) — A new survey reveals the West Coast has lost about 85% of its historical estuary habitat, but the mapping could also help identify restoration opportunities and provide a baseline for predicting future changes.Though large estuaries like the Columbia River have been...

Deputies kill man who allegedly came at them with a knife

COTTAGE GROVE, Ore. (AP) — Deputies shot and killed a man they said came at him with a knife in Cottage Grove.The Lane County Sheriff's Office said it received a report of a dispute between a male and a female but that deputies were unable to locate them.They retuned around 1 a.m. Saturday,...

Ex-Clemson star Kelly Bryant takes over at QB for Missouri

COLUMBIA, Mo. (AP) — Barry Odom never seems stressed about the future, whether the Missouri coach is pondering tough sanctions handed down by the NCAA over a recruiting scandal or the fact that one of the most prolific passers in school history is now in the NFL.When it comes to the...

Missouri DE Williams pleads to misdemeanor, put on probation

COLUMBIA, Mo. (AP) — Missouri defensive end Tre Williams pleaded guilty to a misdemeanor and was sentenced to two years of unsupervised probation after prosecutors dropped a felony domestic assault charge.The Columbia Daily Tribune reports Williams pleaded guilty to peace disturbance and was...

OPINION

Why I’m Visiting the Border

People of color are feeling less safe today and any day when we see the realities of domestic terrorism and racially-motivated acts of violence ...

Why Lady Liberty Weeps

The original concept was to have Lady Liberty holding a broken shackle and chain in her left hand, to commemorate the end of slavery in the United States. ...

Avel Gordly's Statement in Advance of Aug. 17 Rally

'All we have on this planet is one another' ...

A National Crisis: Surging Hate Crimes and White Supremacists

Our history chronicles the range of hate crimes that have taken the lives of Latinos as well as Native Americans, Blacks, Jews, and the LGBTQ community ...

AFRICAN AMERICANS IN THE NEWS

Arkansas, home to supremacist groups, weighs hate crimes law

LITTLE ROCK, Ark. (AP) — Long before a mass shooting killed 22 people at a Walmart in Texas, the threat of white supremacy was well known in neighboring Arkansas, where extremist groups over the decades have made their home in the mountains and dense woods of the state's remote rural...

Biggest ever Kentridge show explores Africa's history

CAPE TOWN, South Africa (AP) — Evocative videos, graphic tapestries, charcoal drawings, woodcut prints, sculptures and immersive sound installations combine in the largest-ever show by South African artist William Kentridge to explore compelling themes including South Africa's apartheid...

Oregon defends past nonunanimous jury verdicts to high court

SALEM, Ore. (AP) — Oregon's criminal justice system would be "overwhelmed" if the U.S. Supreme Court rules in an upcoming case that nonunanimous jury verdicts are unconstitutional, the state's attorney general has told the court.Attorney General Ellen Rosenblum said in an amicus brief on...

ENTERTAINMENT

Beyonce, Sinatra among those on Obama summer song playlist

NEW YORK (AP) — The Obama summer playlist has everyone from Drake and Beyonce to Steely Dan and Frank Sinatra. The former president calls it "some new, some old, some fast, some slow."Barack Obama tweeted 44 songs Saturday that he and his wife, Michelle, have been listening to. They include...

Obi-Wan, Lizzie McGuire join new Disney Plus platform

ANAHEIM, Calif. (AP) — Ewan McGregor is reprising his "Star Wars" role as Obi-Wan Kenobi in a new series, one of the many splashy projects that Disney is banking on to make its new streaming platform competitive.The as-yet untitled Disney Plus show drew big cheers when it was announced...

Latest: Spider-Man Tom Holland tells fans: 'I love you 3000'

ANAHEIM, Calif. (AP) — The Latest on Walt Disney Co.'s biannual D23 fan convention in Anaheim (all times local):12:05 p.m.Tom Holland has made an appearance at a Disney fan convention amid the news that Spider-Man will no longer be part of the Marvel Cinematic Universe.Earlier this week, it...

U.S. & WORLD NEWS

2 Israeli drones crash over Beirut, Hezbollah denies firing

BEIRUT (AP) — Two Israeli drones crashed in a Hezbollah stronghold in the Lebanese capital overnight,...

North Korea tests new 'super-large' rocket launcher

SEOUL, South Korea (AP) — North Korea said Sunday that leader Kim Jong Un supervised the test-firing of a...

Elizabeth Warren's rise started by looking at the bottom

CHICAGO (AP) — As a young scholar, Elizabeth Warren traveled to federal courthouses, studying families...

North Korea tests new 'super-large' rocket launcher

SEOUL, South Korea (AP) — North Korea said Sunday that leader Kim Jong Un supervised the test-firing of a...

Hong Kong police fire tear gas, roll out water cannon trucks

HONG KONG (AP) — Police in Hong Kong used tear gas Sunday to clear pro-democracy demonstrators who had...

The Latest: HK police draw guns as protesters chase them

HONG KONG (AP) — The Latest on Hong Kong protests (all times local):9:35 p.m.Hong Kong police officers have...

McMenamins
Matthew Perrone AP Health Writer

WASHINGTON (AP) -- Federal health authorities recommended Thursday that the blockbuster drug Avastin no longer be used to treat breast cancer, saying recent studies failed to show the drug's original promise to help slow the disease and extend patients' lives.

The rare decision by the Food and Drug Administration is supported by many cancer experts but drew fierce opposition from cancer patients and some doctors who defend the drug and say it should remain available.

The ruling is a significant setback for the world's best-selling cancer drug and will likely cost Swiss drugmaker Roche hundreds of millions of dollars in lost revenue. Avastin is also approved for various types of colon, lung, kidney and brain cancer.

FDA officials stressed that the recommendation is only a preliminary step toward revoking the drug's approval for breast cancer. Roche has refused to voluntarily withdraw the indication, and the company said in a statement it would request a public meeting on the issue.

Drug companies almost always follow FDA requests, and agency officials said a meeting over the fate of Avastin would be the first of its kind. The agency said it will consider whether to hold the meeting in the coming months.

"Today's decision was a difficult one for the agency but certainly not unique," said Dr. Janet Woodcock, director of FDA's drug center. "The FDA is responsible for assuring that the products we approve for patients are both effective and safe."

The FDA approved Avastin for breast cancer in 2008 based on one study suggesting it halted the spread of breast cancer for more than five months when combined with chemotherapy. But follow-up studies showed that the delay lasted no more than three months, and patients suffered dangerous side effects.

"Given the number of serious and life-threatening side effects, the FDA does not believe there is a favorable risk-to-benefit ratio," said Dr. Richard Pazdur, FDA's chief of cancer drug review.

In a separate announcement Thursday, the European Medicines Agency said it would keep the drug available as a combination treatment with the chemotherapy drug paclitaxel - the same use rejected by the FDA.

FDA officials said the split opinion was due to differences in how Avastin was approved in the U.S. versus Europe. The FDA cleared the drug under its accelerated approval program, giving the agency the option to rescind approval if follow-up studies didn't confirm initial results. European regulators granted the drug full approval based on the same results, making it more difficult to reverse course when faced with weaker follow-up results.

If the FDA ultimately removes Avastin's breast cancer indication, doctors will still have the option to prescribe the drug "off-label," or without a federal approval, but many insurers do not reimburse drugs for such uses. Without insurance coverage, Avastin's enormous cost would put it out of reach for most patients. Roche sells the drug at a wholesale price of $7,700 a month. When infusion charges are included, a year's treatment with Avastin can run more than $100,000, though Roche caps spending at $57,000 per year for patients who meet certain financial criteria.

For the time being, the FDA said the drug will remain available and patient care will not be affected.

While vigorously opposed by thousands of cancer patients, the FDA's ruling is in line with the guidance of its outside panel of cancer experts, who voted 12-1 in July to rescind the drug's approval for breast cancer.

Cancer specialists said Avastin never lived up to its initial promise.

"The bottom line is that it doesn't work very well," said Dr. Albert Braverman, chief of oncology at State University of New York Downstate Medical Center. "I've seen the occasional patient have a brief remission, which is nice, but it's certainly not doing anything important. It's not saving anyone's life."

But some patients credit their survival to Avastin and say the FDA's decision could amount to a death sentence.

Christi Turnage of Madison, Miss., said her cancer has been undetectable for more than two years since starting therapy with Avastin. She was diagnosed with breast cancer in June 2006 and began taking the drug in 2008 after the tumors spread, or metastized, to her lungs. Breast cancer that spreads to other parts of the body is generally considered incurable.

"It's a miracle drug for me and for several of my friends, and to deny it to women being diagnosed with metastatic disease is wrong," Turnage said.

More than 9,500 cancer patients and friends and family signed a petition by Turnage urging the FDA to keep Avastin approved.

Dr. Julie Gralow of the Seattle Cancer Care Alliance said the drug appears to work in some subsets of patients and should remain available.

"It is clear that some breast cancer patients derive substantial benefit from Avastin. We don't know how to select those tumors or patients yet," said Gralow, who helped conduct the initial study of Avastin in breast cancer.

Barbara Brenner, director of Breast Cancer Action, a San Francisco-based advocacy group, said the group agrees with FDA's decision.

"It's never been shown to improve survival or quality of life. We know that people will be disappointed, but science has to dictate where we go with drug approval," Brenner said.

She added that women already receiving the drug should be allowed to keep getting it.

Roche reported Avastin sales of nearly $6 billion in 2009.

FDA rules bar the agency from considering cost when making drug approval decisions. But earlier this month the U.K.'s public health service rejected the drug for breast cancer, citing its high cost and limited benefit.

U.S. sales of Avastin for breast cancer generate an estimated $600 million annually, according to analyst David Kaegi of Switzerland's Bank Sarasin. When combined with lost revenue from the U.K., Kaegi estimated Roche's Avastin sales could fall by $1 billion.

The FDA granted Avastin accelerated approval for breast cancer in 2008 based on a study suggesting it delayed the spread of breast cancer for more than five months when combined with a popular chemotherapy drug. However, patients taking the drug did not actually live longer than those taking chemotherapy alone. And FDA officials reiterated Thursday that all four studies of Avastin conducted by Roche failed to show increased survival.

Avastin, which is grown from hamster ovary cells, was the first drug approved to fight cancer by stopping nutrients from reaching tumors. Such "targeted therapies" were thought to hold promise for eliminating chemotherapy, but that promise has gone unmet. Today drugs like Avastin are generally used as a second-line treatment after chemotherapy.

"I think a few years down the line it was becoming increasingly clear, at least to me, that this wasn't a particularly active drug, despite the initial presentation," said Dr. Braverman, referring to Avastin for breast cancer. "But people are sort of on a roll and it takes a while for things to die down."

----

AP Medical Writer Marilynn Marchione contributed to this report from Milwaukee.

mlkbreakfast2020 tickets 300x180

Seattle Pay by Plate
PBOT Drivers Advisory Committee
Calendar

Photo Gallery

Photos and slide shows of local events

Carpentry Professionals